arrow
J

Julián Olalla

university of sevilla
H指数:20
被引数:1,513

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007–2023)

超越监测突变:2007–2023年西班牙传播性HIV耐药性的长期趋势及临床相关性

2026-05-180
OA
Circulating miRNA Signatures Associated with Atherosclerosis and Cardiometabolic Comorbidities in People with HIV

与HIV感染者动脉粥样硬化和 cardiometabolic 并存疾病相关的循环miRNA特征

2026-02-120
OAAI
Lack of association between loneliness, social isolation and inflammation in people living with HIV aged ≥50 years: Results from the sub-study No One Alone-Gesida Study

孤独感、社会隔离与炎症在年龄≥50岁的HIV感染者中缺乏关联:No One Alone-Gesida研究子研究的结果

2025-12-170
PRE
Intensification with a CCR5 inhibitor at ART initiation Modulates IL-18 and Inflammation-Driven Immune Pathways in People with HIV

在ART启动时使用CCR5抑制剂进行强化调节HIV感染者中IL-18和炎症驱动的免疫通路

2025-12-060
OAAI
Barriers and Facilitators of Implementation of the Non-Hospital-Based Administration of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV: Qualitative Data from the HOLA Study

非医院为基础的长效卡博格韦与利匹韦林联合给药在HIV感染者中实施过程中的障碍与促进因素:HOLA研究中的定性数据

2025-08-220
PRE
Markers of Inflammation and Immune Dysfunction and Non-AIDS Cancer Risk in Adults With HIV

炎症和免疫功能障碍的标志物与HIV感染者中的非艾滋病癌症风险

2025-07-010
PRE
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

持久性精英控制器和瞬态精英控制器中的HIV-1水库景观

2024-02-204
OAAI
Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019-2021
2023-12-123
OA
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

新型冠状病毒肺炎恢复期血浆治疗与死亡率的关系: 一项随机临床试验的协作系统评价和荟萃分析

2021-11-2050
OAAI
Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy
2021-11-0846
OAAI